Novel Immunotherapy Approach Boosts Long-Term Survival in Advanced NSCLC Patients Resistant to Immune Checkpoint Inhibitors
(Barcelona, Spain — September 9, 2025) — At the forefront of oncological research, a groundbreaking study revealed at the International ...
